Arthritis National Research Foundation | Immune Boost Capital

vc$36MCo-investsLeads rounds

◆ Fund Size

$36M

◆ Check Size

$0.1M→$0.5M

◆ Location

United States

◆ Activity

Statusactively investing

◆ Links

Website ↗@ImmuneBoostVC on X ↗

◆ Investment Thesis

An evergreen impact investment fund focused on bridging the funding gap between academic discovery and commercial development for immune-mediated diseases, reinvesting 100% of returns into future innovation.

◆ About Arthritis National Research Foundation

Immune Boost Capital (IBC) is a philanthropic evergreen venture fund, a subsidiary of the Arthritis National Research Foundation, focused on investing in early-stage autoimmune diagnostics, therapeutics, and enabling technologies.[1][2] It provides catalytic proof-of-concept capital up to $500,000 to academic spinouts and emerging biotechs to bridge the funding gap between discovery and commercial development, reinvesting 100% of returns to fuel future innovation.[4][5] IBC operates independently with guidance from experienced investors, scientists, and healthcare leaders, emphasizing strategic partnerships and co-investments.[1][3]

◆ Sectors

BiotechDiagnosticsDrug DiscoveryMedtechDigital Health

◆ Stages

pre-seedseed

◆ Geography Focus

Global

◆ Team

Name	Title	Role	Links
Ayo Akande	Board Member, IBC	Senior
DB Kartik	Board Member, IBC	Senior
Emily Stormoen	Director of Operations (IBC) / Chief Executive Officer (ANRF)	Senior
Jeff Greenberg	Venture Partner / Chair, IBC	Senior
KT Moortgat	Secretary, IBC	Senior
Leonard Dragone	Treasurer, IBC	Senior
Piet van der Graaf	Board Member, IBC	Senior
Rich Narido	Board Member, IBC	Senior
Sai Nandi	Founder & Managing Partner / Fund Principal	Senior
Schalon Newton	Venture Partner / Vice Chair, IBC	Senior
Daniel Greenberg	Intern	Junior
David Johnson	Intern	Junior
Emily Boyd Stormoen	Chief Executive Officer	—	in
Sun Kim	Intern	Junior
Taylor Forte	Intern	Junior

◆ Tracked Investments

geoSurge

◆ Notable Investments

Early-career arthritis and autoimmune disease research grants across 109 institutionsPsoriatic arthritis research supported by Johnson & Johnson Innovative MedicinePediatric joint and skin disease research through Rheum for Kids

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Immune Boost Capital invest in?

Immune Boost Capital invests in Biotech, Diagnostics, Drug Discovery, Medtech and Digital Health at the pre-seed and seed stages.

Which geographies does Immune Boost Capital focus on?

Immune Boost Capital focuses on Global, and is headquartered in United States.

What is Immune Boost Capital's typical check size?

Immune Boost Capital typically writes checks of $0.1M to $0.5M.

Which startups has Immune Boost Capital backed?

Immune Boost Capital has 1 tracked investment on Fusion42, including geoSurge.